Atazanavir — Discount Pricing
Atazanavir is not confirmed for no-additional-cost pricing. Discount pricing may be available; confirm the price with the dispensing pharmacy.
Atazanavir Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | Discount pricing may be available |
| Typical Retail | $131.00 |
Discount pricing may be available; confirm the price with the dispensing pharmacy.
About Atazanavir
Atazanavir is a prescription medication. Ask your doctor if Atazanavir is right for you.
How to Check Atazanavir Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available discount pricing
Atazanavir at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
Other medications in Infections
About Atazanavir
Atazanavir is a crucial antiretroviral medication used in the comprehensive treatment of HIV-1 infection, helping to manage the virus and improve patient health. Understanding your treatment options and prescription costs is important. TheDrugClub is dedicated to helping members access significant savings on essential medications like Atazanavir, making your health journey more affordable.
The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.
What Atazanavir is approved for (FDA label)
Atazanavir capsule is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults and in pediatric patients 6 years and older weighing at least 15 kg.
Source: Read the full FDA label on DailyMed. Label effective date: August 6, 2025.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Dosage forms and strengths for Atazanavir (FDA label)
100 mg Capsules are blue/white size ‘2’ hard gelatin capsule filled with off-white to pale yellow granular powder and imprinted with ‘100 mg’ on blue cap with white edible ink and ‘T23’ on white body with black edible ink. 150 mg Capsules are blue/powder blue size ‘1’ hard gelatin capsule filled with off-white to pale yellow granular powder and imprinted with ‘150 mg’ on blue cap and ‘T24’ on powder blue body with white edible ink. 200 mg Capsules are blue/blue size ‘0’ hard gelatin capsule filled with off-white to pale yellow granular powder and imprinted with ‘200 mg’ on blue cap and ‘T25’ on blue body with white edible ink. 300 mg Capsules are red/blue size ‘00’ hard gelatin capsule filled with off-white to pale yellow granular powder and imprinted with ‘300 mg’ on red cap and ‘T26’ on blue body with white edible ink.
Source: FDA prescribing information (DailyMed). Set ID: 7fbea274-d6b5-4faa-bbf0-05fefab42114. SPL document ID: 8f8c56e0-40ee-4643-88f7-d3571ff5a409. Label effective date: August 6, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Atazanavir (FDA label)
The following adverse reactions are discussed in greater detail in other sections of the labeling: cardiac conduction abnormalities [see Warnings and Precautions (5.1) ] rash [see Warnings and Precautions (5.2) ] hyperbilirubinemia [see Warnings and Precautions (5.8) ] chronic kidney disease [see Warnings and Precautions (5.5) ] nephrolithiasis and cholelithiasis [ see Warnings and Precautions (5.6) ] Most common adverse reactions (≥2%) are nausea, jaundice/scleral icterus, rash, headache, abdominal pain, vomiting, insomnia, peripheral neurologic symptoms, dizziness, myalgia, diarrhea, depression, and fever. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Aurobindo Pharma USA, Inc. at 1-866-850-2876 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch . 6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
Source: FDA prescribing information (DailyMed). Set ID: 7fbea274-d6b5-4faa-bbf0-05fefab42114. SPL document ID: 8f8c56e0-40ee-4643-88f7-d3571ff5a409. Label effective date: August 6, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Atazanavir (FDA label)
Atazanavir capsules are contraindicated: in patients with previously demonstrated clinically significant hypersensitivity (e.g., Stevens-Johnson syndrome, erythema multiforme, or toxic skin eruptions) to any of the components of atazanavir capsules [see Warnings and Precautions (5.2) ]. when coadministered with drugs that are highly dependent on CYP3A or UGT1A1 for clearance, and for which elevated plasma concentrations of the interacting drugs are associated with serious and/or life-threatening events (see Table 6). when coadministered with drugs that are strong inducers of CYP3A due to the potential for loss of therapeutic effect and development of resistance.
Source: FDA prescribing information (DailyMed). Set ID: 7fbea274-d6b5-4faa-bbf0-05fefab42114. SPL document ID: 8f8c56e0-40ee-4643-88f7-d3571ff5a409. Label effective date: August 6, 2025. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.